1. A first‐in‐man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM‐1 receptor inhibition. (20th July 2018) Authors: Cuvier, Valerie; Lorch, Ulrike; Witte, Stephan; Olivier, Aurelie; Gibot, Sebastien; Delor, Isabelle; Garaud, Jean‐Jacques; Derive, Marc; Salcedo‐Magguilli, Margarita Journal: British journal of clinical pharmacology Issue: Volume 84:Number 10(2018) Page Start: 2270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. Issue 6 (19th January 2018) Authors: Jolly, Lucie; Carrasco, Kevin; Derive, Marc; Lemarié, Jérémie; Boufenzer, Amir; Gibot, Sébastien Journal: Cardiovascular research Issue: Volume 114:Issue 6(2018) Page Start: 907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗